| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A novel application of XPO1 inhibition for the treatment of myelofibrosis
|
Metzger, Megan
|
|
|
1 |
2 |
p.
|
artikel
|
| 2 |
CD302 predicts achievement of deep molecular response in patients with chronic myeloid leukemia treated with imatinib
|
Kok, Chung Hoow
|
|
|
1 |
2 |
p.
|
artikel
|
| 3 |
Central role of the mTORC1 pathway in glucocorticoid activity against B-ALL cells
|
Imanaga, Hiroshi
|
|
|
1 |
2 |
p.
|
artikel
|
| 4 |
Competition of dual SF3B1 mt clones in MDS-RS is associated with distinct RNA mis-splicing in hematopoietic stem cells
|
Moura, Pedro Luis
|
|
|
1 |
2 |
p.
|
artikel
|
| 5 |
Devimistat plus chemotherapy vs chemotherapy alone for older relapsed or refractory patients with AML: results of the ARMADA trial
|
Pardee, Timothy S.
|
|
|
1 |
2 |
p.
|
artikel
|
| 6 |
Frequent response monitoring in chronic lymphocytic leukemia clinical trials: what is the value?
|
Mattsson, Agnes
|
|
|
1 |
2 |
p.
|
artikel
|
| 7 |
Long-term remission with allogeneic transplant in patients with refractory/relapsed cutaneous cytotoxic T-cell lymphoma
|
Weng, Wen-Kai
|
|
|
1 |
2 |
p.
|
artikel
|
| 8 |
Prospective performance of the IWG-2023 criteria and IPSS-M in a phase 2 trial of guadecitabine for higher-risk MDS or CMML
|
Urrutia, Samuel
|
|
|
1 |
2 |
p.
|
artikel
|
| 9 |
Saliva as a feasible alternative to blood for interrogation of somatic hematopoietic variants
|
Soyfer, Eli M.
|
|
|
1 |
2 |
p.
|
artikel
|
| 10 |
The landscape of rare genetic variants in familial Waldenström macroglobulinemia
|
Pemov, Alexander
|
|
|
1 |
2 |
p.
|
artikel
|
| 11 |
Venetoclax and hypomethylating agents in octogenarians and nonagenarians with acute myeloid leukemia
|
Madarang, Ellen
|
|
|
1 |
2 |
p.
|
artikel
|
Tijdschrift beschrijving